Aureobasidium.org

Review 2003

Fungal β-Glucans and Mammalian Immunity

Brown G., Gordon S. · Immunity · DOI: 10.1016/S1074-7613(03)00233-4
Research Archive
TL;DR — Key Findings
  • Fungal beta-glucans engage mammalian innate immune recognition.
  • Receptor and signaling mechanisms are reviewed.
  • The paper does not prove a clinical product benefit.

Abstract

This review explains how fungal beta-glucans are recognized by mammalian innate immunity and summarizes receptor and signaling research relevant to antifungal, anti-infective, and tumor-related hypotheses. It reflects an early stage of mechanistic understanding and discusses a heterogeneous literature. The review does not itself demonstrate clinical efficacy, and findings about fungal beta-glucans cannot automatically be generalized to a specific product or route of administration.

Summary

Summary

Scope

Review of fungal beta-glucan recognition and mammalian innate-immune mechanisms.

Interpretation

Mechanistic context does not establish clinical efficacy or interchangeability of products.

AI-generated summary for accessibility. Always refer to the original paper.

Citation

Brown G., Gordon S.. Fungal β-Glucans and Mammalian Immunity. Immunity. 2003. DOI: 10.1016/S1074-7613(03)00233-4.

Study Details
Study Type
Review
Published
2003
Journal
Immunity
Authors
Brown G., Gordon S.
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.